Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (241-250 of 501) with videos related to

Pageof 51
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 20, 2024
Tumescent local anesthesia in geriatric patients with head and neck skin cancer - a retrospective study of 782 patientsSaskia Maria Schnabl, Claus Garbe, Helmut Breuninger, et al.
Experimental Dermatology|June 26, 2003
Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanomaFriedegund Meier, Ulrich Caroli, Kapaettu Satyamoorthy, et al.
Pigment Cell & Melanoma Research|April 5, 2011
The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytesDieter Leupold, Matthias Scholz, Goran Stankovic, et al.
Cancers|April 26, 2020
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV MelanomaTeresa Amaral, Olivia Seeber, Edgar Mersi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patientsBenjamin Weide, Steve Pascolo, Birgit Scheel, et al.
JAMA Dermatology|August 4, 2021
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysisTheresa Steeb, Anja Wessely, Anne Petzold, et al.
Acta Dermato-Venereologica|December 15, 2018
Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control StudyLina Maria Serna-Higuita, Simone L Harrison, Petra Buttner, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
Pageof 51

Showing results (241-250 of 501) with videos related to

Sort By:
Pageof 51
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 20, 2024
Tumescent local anesthesia in geriatric patients with head and neck skin cancer - a retrospective study of 782 patientsSaskia Maria Schnabl, Claus Garbe, Helmut Breuninger, et al.
Experimental Dermatology|June 26, 2003
Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanomaFriedegund Meier, Ulrich Caroli, Kapaettu Satyamoorthy, et al.
Pigment Cell & Melanoma Research|April 5, 2011
The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytesDieter Leupold, Matthias Scholz, Goran Stankovic, et al.
Cancers|April 26, 2020
Primary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV MelanomaTeresa Amaral, Olivia Seeber, Edgar Mersi, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patientsBenjamin Weide, Steve Pascolo, Birgit Scheel, et al.
JAMA Dermatology|August 4, 2021
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysisTheresa Steeb, Anja Wessely, Anne Petzold, et al.
Acta Dermato-Venereologica|December 15, 2018
Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control StudyLina Maria Serna-Higuita, Simone L Harrison, Petra Buttner, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
Pageof 51